Myocardial fibrosis is one of the histologic constituents of myocardial rem
odeling present in hypertensive patients with hypertensive heart disease. I
n fact, an exaggerated interstitial and perivascular accumulation of fibril
lar collagens type I and type III has been found in the myocardium of patie
nts with arterial hypertension and left ventricular hypertrophy. Hypertensi
ve myocardial fibrosis has been shown to facilitate abnormalities of cardia
c function, coronary reserve, and electrical activity that adversely affect
the clinical outcome of hypertensive patients. Therefore, development of n
oninvasive tools for the monitoring of myocardial fibrosis and pharmacologi
cal strategies aimed to promote the regression of fibrosis could be of part
icular relevance in the clinical treatment of patients with hypertensive he
art disease. (C) 2001 Lippincott Williams & Wilkins, Inc.